eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Craniofacial Surgery

Distraction Osteogenesis of the Maxilla

Author: Anil R Shah, MD, Plastic Surgeon, Private Practice
Coauthor(s): Daniel G Danahey, MD, PhD, Consulting Staff, Michiana Eye Center and Facial Plastic Surgery
Contributor Information and Disclosures

Updated: Feb 11, 2009

Introduction

Distraction osteogenesis is a surgical technique for reconstruction of bony deformities. Increased amounts of both bone and soft tissue are created as a result of the gradual displacement of surgically created bony fractures. Because distraction techniques generate new bone, the morbidity of harvesting bone from other sites is obviated.

In terms of techniques, traditional advancement of the mid face with osteotomies and harvesting of bone grafts are associated with high rates of midface regression and morbidity. Distraction in the mid face decreases intraoperative morbidity and rates of postoperative midface regression. Both of these factors have led to an increase in the popularity of midface distraction, demonstrated in a survey of craniofacial surgeons, who reported that the mid face was the site of distraction in 28% of their cases.

Views of a person with Apert syndrome are below.

Frontal view of a patient with Apert syndrome. No...

Frontal view of a patient with Apert syndrome. Note the classic stigmata of exophthalmos, hypoplastic maxilla, saddle-nose deformity, and craniofacial dysostosis.

Frontal view of a patient with Apert syndrome. No...

Frontal view of a patient with Apert syndrome. Note the classic stigmata of exophthalmos, hypoplastic maxilla, saddle-nose deformity, and craniofacial dysostosis.


Lateral view of a patient with Apert syndrome. No...

Lateral view of a patient with Apert syndrome. Note the orbital exorbitism and maxillary deficiency.

Lateral view of a patient with Apert syndrome. No...

Lateral view of a patient with Apert syndrome. Note the orbital exorbitism and maxillary deficiency.


History of the Procedure

Osteogenic distraction is the result of the evolution of techniques for bone fixation, skeletal traction, and osteotomy. Osteogenic distraction was first used in orthopedics to lengthen bones after planned osteotomies. However, the complication rate remained high and the technique was not understood until Gavriel Ilizarov, a Russian orthopedic surgeon, performed detailed studies in 1952. Working in a rural clinic in Siberia, Ilizarov did not have the requisite equipment for surgeons used at that time. Therefore, he performed studies by using his own equipment and procedures, which proved to be more effective than contemporary procedures, as evidenced by modern day use of his methods.

Distraction of the maxilla was first performed by expanding the midpalatal suture in monkeys in 1965. The first human application of maxillary distraction in craniofacial surgery was a mandible distraction in 1989. Case reports of its application in maxillary distraction were published in 1992.

Pathophysiology

The principle of distraction osteogenesis is based on new bone formation that develops when tension forces are applied. This new bone formation is a result of membranous ossification.

The viability of bone cells (osteocytes and osteoblasts) is crucial in distraction osteogenesis. Bone viability can be enhanced by limiting damage to the cortex by making distinct cuts. Bone viability can also be enhanced by preserving the blood supply to the bone, which is necessary for its growth, by leaving adequate soft tissue coverage. Endothelial cells may stimulate angiogenesis and play an important role as well.

Distraction histogenesis is a term that describes the gradual increase in soft tissue volume in response to the stress forces applied with bony distraction. Traditional midface techniques provide immediate bony correction but do not allow for compensatory growth of the soft tissues. As a result of scarring and memory, the soft tissue often contracts to its preoperative state. This is thought to be the main reason for the high rate of relapse of midface insufficiency after the use of traditional techniques. In contrast, distraction techniques create a gradual increase in the amount of soft tissue by preventing its contraction.

Indications

Indications for distraction osteogenesis of the maxilla are craniofacial anomalies, facial clefts, severe sleep apnea, hemifacial microsomia, a deficient alveolar ridge, and complex trauma.

Craniofacial anomalies account for most indications for maxillary distraction. Distraction may improve aesthetic contouring of the face, resolve sleep apnea, and improve orthognathics. Distraction can be applied to a wide variety of anomalies with maxillary deficiency; Crouzon syndrome and Pfeiffer syndrome account for most of the reported cases. Advancement of the lower maxilla, as in a Le Fort I osteotomy, or complete midfacial advancement, as in a Le Fort III procedure, can be accomplished. Distraction cannot only achieve the aesthetic goals of realignment but also apnea resolves, obviating tracheostomy.

Patients with facial clefting often have maxillary hypoplasia. Even after cleft repair and orthodontic treatment, severe maxillary deficiency may persist. These patients traditionally undergo repair with Le Fort I osteotomy advancement with internal fixation. This approach often fails because of palatal scarring, soft tissue memory, and scar formation. External distraction leads to slow expansion of the surrounding tissues, allowing the body to accommodate the new position of the maxilla. Krimmel et al found that external distraction is superior to traditional techniques in patients who have facial clefting with maxillary hypoplasia.1

Sleep apnea in select adults with a deficiency in their upper airway dimension may be an indication for distraction.

Hemifacial microsomia may respond to a combination of maxillomandibular distraction. Satoh et al found that distraction osteogenesis is a safe and effective method for reducing the use of orthodontic appliances to 7-14 years.2

A deficient alveolar ridge is another indication for maxillary distraction. A deficiency of the alveolar ridge may be the result of circumstances, such as traumatic avulsion of mandibular incisor teeth or a congenital deformity. Expansion of the alveolar housing creates a site for the placement of a dental implant. This may improve ridge aesthetics for a pontic, or replacement, artificial tooth or teeth that are mounted on a fixed or removable dental appliance, and it may expand the alveolus to allow for orthodontic tooth movement.

Distraction may also be indicated in cases of complex, high-impact midface fractures, especially for the delayed repair of bony fractures of the mid face.

Contraindications

As long as the bone where the distraction device is placed is adequate, the procedure has few contraindications. Young patients must be selected carefully because of their fragile bones and because the amount of bone available for device placement may be inadequate. In infants, numerous studies have demonstrated successful results with the careful selection of infants, with no untoward effects. The surgeon must preoperatively confirm that the strength of the transport and anchorage segments is adequate to withstand forces of mobilization and transport.

Skeletal deformities resulting from bone disease are not a contraindication, as long as enough bone for distraction is available.

Last, the patient's participation is as important as the procedure itself. A noncompliant patient can cause any distraction procedure to fail.

More on Distraction Osteogenesis of the Maxilla

Overview: Distraction Osteogenesis of the Maxilla
Workup: Distraction Osteogenesis of the Maxilla
Treatment: Distraction Osteogenesis of the Maxilla
Follow-up: Distraction Osteogenesis of the Maxilla
Multimedia: Distraction Osteogenesis of the Maxilla
References

References

  1. Krimmel M, Cornelius CP, Roser M, Bacher M, Reinert S. External distraction of the maxilla in patients with craniofacial dysplasia. J Craniofac Surg. Sep 2001;12(5):458-63. [Medline].

  2. Satoh K, Suzuki H, Uemura T, Hosaka Y. Maxillo-mandibular distraction osteogenesis for hemifacial microsomia in children. Ann Plast Surg. Dec 2002;49(6):572-8; discussion 578-9. [Medline].

  3. Guyette TW, Polley JW, Figueroa A, Smith BE. Changes in speech following maxillary distraction osteogenesis. Cleft Palate Craniofac J. May 2001;38(3):199-205. [Medline].

  4. Harada K, Baba Y, Ohyama K, Omura K. Soft tissue profile changes of the midface in patients with cleft lip and palate following maxillary distraction osteogenesis: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Dec 2002;94(6):673-7. [Medline].

  5. Krimmel M, Cornelius CP, Bacher M, Gülicher D, Reinert S. Longitudinal cephalometric analysis after maxillary distraction osteogenesis. J Craniofac Surg. Jul 2005;16(4):683-8. [Medline].

  6. Wong GB, Padwa BL. LeFort I soft tissue distraction: a hybrid technique. J Craniofac Surg. Jul 2002;13(4):572-6; discussion 577. [Medline].

  7. Iannetti G, Fadda T, Agrillo A, Poladas G, Iannetti G, Filiaci F. LeFort III advancement with and without osteogenesis distraction. J Craniofac Surg. May 2006;17(3):536-43. [Medline].

  8. Koudstaal MJ, Smeets JB, Kleinrensink GJ, Schulten AJ, van der Wal KG. Relapse and stability of surgically assisted rapid maxillary expansion: an anatomic biomechanical study. J Oral Maxillofac Surg. Jan 2009;67(1):10-4. [Medline].

  9. Cohen SR. Midface distraction. Semin Orthod. Mar 1999;5(1):52-8. [Medline].

  10. Fan H, Wang X, Lin Y, Zhou Y, Yi B, Li Z. [Application of distraction osteogenesis in severe maxillary hypoplasia secondary to cleft palate]. Zhonghua Yi Xue Za Zhi. May 25 2002;82(10):699-702. [Medline].

  11. Ghysen D, Ozsarlak O, van den Hauwe L, et al. Maxillo-facial trauma. JBR-BTR. Aug 2000;83(4):181-92. [Medline].

  12. Harada K, Ishii Y, Ishii M, Imaizumi H, Mibu M, Omura K. Effect of maxillary distraction osteogenesis on velopharyngeal function: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. May 2002;93(5):538-43. [Medline].

  13. Harada K, Sato M, Omura K. Long-term skeletal and dental changes in patients with cleft lip and palate after maxillary distraction: a report of three cases treated with a rigid external distraction device. Cranio. Apr 2005;23(2):152-7. [Medline].

  14. Hierl T, Klöppel R, Hemprich A. Midfacial distraction osteogenesis without major osteotomies: a report on the first clinical application. Plast Reconstr Surg. Nov 2001;108(6):1667-72. [Medline].

  15. Kessler P, Wiltfang J, Schultze-Mosgau S, Hirschfelder U, Neukam FW. Distraction osteogenesis of the maxilla and midface using a subcutaneous device: report of four cases. Br J Oral Maxillofac Surg. Feb 2001;39(1):13-21. [Medline].

  16. Ko EW, Figueroa AA, Guyette TW, Polley JW, Law WR. Velopharyngeal changes after maxillary advancement in cleft patients with distraction osteogenesis using a rigid external distraction device: a 1-year cephalometric follow-up. J Craniofac Surg. Jul 1999;10(4):312-20; discussion 321-2. [Medline].

  17. Li KK, Powell NB, Riley RW, Guilleminault C. Distraction osteogenesis in adult obstructive sleep apnea surgery: a preliminary report. J Oral Maxillofac Surg. Jan 2002;60(1):6-10. [Medline].

  18. Matsumoto K, Nakanishi H, Koizumi Y, et al. Segmental distraction of the midface in a patient with Crouzon syndrome. J Craniofac Surg. Mar 2002;13(2):273-8. [Medline].

  19. Meling TR, Tveten S, Due-Tonnessen BJ, Skjelbred P, Helseth E. Monobloc and midface distraction osteogenesis in pediatric patients with severe syndromal craniosynostosis. Pediatr Neurosurg. Aug 2000;33(2):89-94. [Medline].

  20. Morovic CG, Monasterio L. Distraction osteogenesis for obstructive apneas in patients with congenital craniofacial malformations. Plast Reconstr Surg. Jun 2000;105(7):2324-30. [Medline].

  21. Papageorge MB. Distraction osteogenesis for augmentation of the deficient alveolar ridge. J Mass Dent Soc. Spring 2002;51(1):24-30, 51. [Medline].

  22. Polley JW, Figueroa AA. Maxillary distraction osteogenesis with rigid external distraction. Atlas Oral Maxillofac Surg Clin North Am. Mar 1999;7(1):15-28. [Medline].

  23. Rachmiel A, Jackson IT, Potparic Z, Laufer D. Midface advancement in sheep by gradual distraction: a 1-year follow-up study. J Oral Maxillofac Surg. May 1995;53(5):525-9. [Medline].

  24. Swennen G, Dempf R, Schliephake H. Cranio-facial distraction osteogenesis: a review of the literature. Part II: Experimental studies. Int J Oral Maxillofac Surg. Apr 2002;31(2):123-35. [Medline].

  25. Swennen G, Schliephake H, Dempf R, Schierle H, Malevez C. Craniofacial distraction osteogenesis: a review of the literature: Part 1: clinical studies. Int J Oral Maxillofac Surg. Apr 2001;30(2):89-103. [Medline].

  26. Uemura T, Hayashi T, Satoh K, et al. A case of improved obstructive sleep apnea by distraction osteogenesis for midface hypoplasia of an infantile Crouzon's syndrome. J Craniofac Surg. Jan 2001;12(1):73-7. [Medline].

Further Reading

Keywords

distraction osteogenesis of the maxilla, distraction osteogenesis, osteogenesis, bone deformities, reconstructive surgery, Crouzon syndrome, Crouzon's syndrome, Pfeiffer syndrome, Pfeiffer's syndrome, Apert syndrome, Apert's syndrome, maxillary distraction, midface distraction, bony distraction, bony deformities, bone increases, bone generation

Contributor Information and Disclosures

Author

Anil R Shah, MD, Plastic Surgeon, Private Practice
Anil R Shah, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, and Triological Society
Disclosure: Nothing to disclose.

Coauthor(s)

Daniel G Danahey, MD, PhD, Consulting Staff, Michiana Eye Center and Facial Plastic Surgery
Daniel G Danahey, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, Sigma Xi, and Triological Society
Disclosure: Nothing to disclose.

Medical Editor

Mimi S Kokoska, MD, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences; Chief, Department of Otolaryngology-Head and Neck Surgery, Central Arkansas Veterans Healthcare System
Mimi S Kokoska, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, American College of Surgeons, American Head and Neck Society, and Arkansas Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Robert M Kellman, MD, Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York, Upstate Medical University
Robert M Kellman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Rhinologic Society, American Society for Head and Neck Surgery, Medical Society of the State of New York, and Triological Society
Disclosure: GE Healthcare Honoraria Review panel membership

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.